Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1587 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Bausch + Lomb Buys Zirgan From Sirion

Zirgan was approved by the FDA as a topical anti-viral for the treatment of acute herpetic keratitis (corneal ulcers). In 2007, Sirion Therapeutics acquired a license for the